T cell-dependence of Lassa fever pathogenesis.
T cell-dependence of Lassa fever pathogenesis.
复制标题
DOI:
10.1371/journal.ppat.1000836
复制
发表时间:
2010-03-26
期刊:
影响因子:
6.7
通讯作者:
Pinschewer DD
中科院分区:
文献类型:
--
作者:
Flatz L;Rieger T;Merkler D;Bergthaler A;Regen T;Schedensack M;Bestmann L;Verschoor A;Kreutzfeldt M;Brück W;Hanisch UK;Günther S;Pinschewer DD
Lassa virus (LASV), the causative agent of Lassa fever (LF), is endemic in West Africa, accounting for substantial morbidity and mortality. In spite of ongoing research efforts, LF pathogenesis and mechanisms of LASV immune control remain poorly understood. While normal laboratory mice are resistant to LASV, we report that mice expressing humanized instead of murine MHC class I (MHC-I) failed to control LASV infection and develop severe LF. Infection of MHC-I knockout mice confirmed a key role for MHC-I-restricted T cell responses in controlling LASV. Intriguingly we found that T cell depletion in LASV-infected HHD mice prevented disease, irrespective of high-level viremia. Widespread activation of monocyte/macrophage lineage cells, manifest through inducible NO synthase expression, and elevated IL-12p40 serum levels indicated a systemic inflammatory condition. The absence of extensive monocyte/macrophage activation in T cell-depleted mice suggested that T cell responses contribute to deleterious innate inflammatory reactions and LF pathogenesis. Our observations in mice indicate a dual role for T cells, not only protecting from LASV, but also enhancing LF pathogenesis. The possibility of T cell-driven enhancement and immunopathogenesis should be given consideration in future LF vaccine development. Lassa virus (LASV) is the causative agent of Lassa fever (LF), accounting for substantial morbidity and mortality in West Africa. Yet the mechanisms leading to disease remain poorly understood. Here we propose a concept whereby the body's immune defense either defeats LASV rapidly or, if unsuccessful, becomes an essential facilitator of disease. This latter paradoxical postulate stems from observations in genetically engineered (HHD) mice, which we found to be susceptible to LF. HHD mice differ from resistant wild type mice in that they have a humanized repertoire of T cells, a main component of the mammalian immune system. Counterintuitively, we could protect HHD mice against LF by experimentally removing their T cells. We further found that LF correlated with widespread activation of macrophages, which again depended on T cells. Similar to T cells, macrophages are important players in our body's defense system, but their inflammatory products are also candidate mediators of LF. Taken together, these findings suggest that LF may represent an inappropriate host response to infection. Specifically, our study demonstrates a two-faced role of T cell responses against LASV. Such detrimental aspects of immune defense need to be given consideration in future LF vaccine development, to avoid enhancement of disease in vaccinated individuals.
登录
查看更多内容
DOI:
10.4269/ajtmh.1970.19.670
发表时间:
1970-01-01
影响因子:
3.3
作者:
FRAME, JD;BALDWIN, JM;TROUP, JM
通讯作者:
TROUP, JM
影响因子:
5.4
作者:
JAHRLING, PB;PETERS, CJ
通讯作者:
PETERS, CJ
DOI:
10.1084/jem.20070784
发表时间:
2007-10-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Almeida JR;Price DA;Papagno L;Arkoub ZA;Sauce D;Bornstein E;Asher TE;Samri A;Schnuriger A;Theodorou I;Costagliola D;Rouzioux C;Agut H;Marcelin AG;Douek D;Autran B;Appay V
通讯作者:
Appay V
影响因子:
5.4
作者:
Asper, M;Sternsdorf, T;Günther, S
通讯作者:
Günther, S
影响因子:
5.4
作者:
Botten, Jason;Alexander, Jeff;Buchmeier, Michael J.
通讯作者:
Buchmeier, Michael J.